This Drug Reduces 99% HIV Risk

Instead of giving patients a pill every day, the new drug, Apretude, is given to them every two months instead.

Photo by Towfiqu barbhuiya on Unsplash

This is the first long-acting injectable drug that can be used for HIV pre-exposure prevention or PrEP. The FDA announced Monday that it has approved the first long-acting…




Great things are coming…

Love podcasts or audiobooks? Learn on the go with our new app.

Recommended from Medium

American Psychiatric Association Psychiatric News Alert

Health For All: 5 Reasons We’re Betting Big on NTD Programs

Body Reactions to Injuries and Possible Treatments

Opinion | Living With H.I.V. Isn’t a Crime. Why Is the United States Treating It Like One?


5 Tips to Protect Your Eyes From Digital Screens

What It’s Like to Lose a Child Patient

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store


Great things are coming…

More from Medium

Time to be blunt: cannabis is good for your economy

Tom signs off on an incredible career, but what is next for Tampa Bay?

I Can See Clearly Now

Travel.P #59 — Furkapass, Glaciers and beyond that